 OncoSec Medical NASDAQ:ONCS had its target price dropped by Alliance Global Partners from 9.00 to 6.50 in a research note issued to investors on Tuesday, The Fly reports. The firm currently has a buy rating on the biotechnology companys stock. Alliance Global Partners target price points to a potential upside of 113.11 from the stocks ... 